Progesterone Capsule
Product Images NDC 73190-065

6 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 73190-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Progesterone Capsules 1)

Chem Structure (Progesterone Capsules 1)
Chemical structure of progesterone, showing its steroid backbone with characteristic four-ring structure and functional groups, consistent with the hormone's molecular configuration.*
FDA Label Image

Figure 1 (Progesterone Capsules 2)

Figure 1 (Progesterone Capsules 2)
A line graph showing the probability of hyperplasia over time in months (0 to 36 months) on medication. The graph compares four groups: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), Placebo Only, with patient counts noted at intervals (0, 12, 24, 36 months). The highest probability is seen in the Conjugated Estrogens Alone group, followed by the other groups with lower probabilities.*
FDA Label Image

1 (Table 5)

FDA Label Image

1 (Table 6)

FDA Label Image

1 (73190 064 01)

FDA Label Image

1 (73190 065 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.